Skip to Content

IDEXX Laboratories Inc IDXX

Rating as of

Morningstar’s Analysis

Currency in USD
Is it the right time to buy or sell?
Find out with Morningstar Premium
Is it the right time to buy or sell?
Find out with Morningstar Premium

1-Star Price


5-Star Price


Economic Moat


Capital Allocation


Idexx Sees Slowing in Third Quarter but Remains on Track With Our Projections: No Change to Our FVE

Debbie S. Wang Senior Equity Analyst

Analyst Note

| Debbie S. Wang |

Idexx Labs posted strong third-quarter results that were largely consistent with our expectations and leave the firm on track to meet our full-year projections; we’re standing pat on our $301 fair value estimate. Some investors may have been disappointed by the slowing year-over-year growth in the rapid assay and reference lab product lines. However, we think this fits into the shifting patterns spurred by the pandemic and the usual seasonality seen in Idexx’s companion animal business. On one hand, vet services typically peak in the second quarter during the warm weather months, but that period in 2020 was subject to lockdown orders that led to pent-up demand that was unleashed in third quarter, making for a challenging year-over-year comparison. On the other hand, we think 2021 is reverting to the more typical seasonality with vet services peaking in second quarter again, which led to a more muted third-quarter performance. Either way, we see little to change our view of Idexx’s narrow moat and continue to think it will be difficult for competitors to catch up to this front-runner.

Read Full Analysis

Company Profile

Business Description

Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.

One IDEXX Drive
Westbrook, ME, 04092
T +1 207 556-0300
Sector Healthcare
Industry Diagnostics & Research
Most Recent Earnings Sep 30, 2021
Fiscal Year End Dec 31, 2021
Stock Type Aggressive Growth
Employees 9,300